- Home
- VALN vs RXST Comparison
VALN vs RXST Comparison
Compare VALN & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- RXST
- Stock Information
- Founded
- VALN 2012
- RXST 1997
- Country
- VALN France
- RXST United States
- Employees
- VALN N/A
- RXST N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VALN Health Care
- RXST Health Care
- Exchange
- VALN Nasdaq
- RXST Nasdaq
- Market Cap
- VALN 542.5M
- RXST 553.1M
- IPO Year
- VALN 2021
- RXST 2021
- Fundamental
- Price
- VALN $6.59
- RXST $7.47
- Analyst Decision
- VALN Strong Buy
- RXST Hold
- Analyst Count
- VALN 3
- RXST 12
- Target Price
- VALN $15.33
- RXST $18.45
- AVG Volume (30 Days)
- VALN 14.9K
- RXST 1.9M
- Earning Date
- VALN 08-12-2025
- RXST 08-07-2025
- Dividend Yield
- VALN N/A
- RXST N/A
- EPS Growth
- VALN N/A
- RXST N/A
- EPS
- VALN N/A
- RXST N/A
- Revenue
- VALN $201,099,222.00
- RXST $148,310,000.00
- Revenue This Year
- VALN $18.74
- RXST $17.41
- Revenue Next Year
- VALN $29.26
- RXST $12.44
- P/E Ratio
- VALN N/A
- RXST N/A
- Revenue Growth
- VALN 21.64
- RXST 46.70
- 52 Week Low
- VALN $3.62
- RXST $6.32
- 52 Week High
- VALN $8.66
- RXST $58.23
- Technical
- Relative Strength Index (RSI)
- VALN 72.04
- RXST 20.31
- Support Level
- VALN $5.82
- RXST $6.32
- Resistance Level
- VALN $6.19
- RXST $8.50
- Average True Range (ATR)
- VALN 0.31
- RXST 0.70
- MACD
- VALN 0.11
- RXST -0.55
- Stochastic Oscillator
- VALN 100.00
- RXST 15.31
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.